Abstract
Read the full review for this Faculty Opinions recommended article: Efficacy of omalizumab, an anti-immunoglobulin E antibody, in patients with allergic asthma at high risk of serious asthma-related morbidity and mortality.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have